Details of the Target
General Information of Target
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DBIA Probe Info |
![]() |
C1122(2.41) | LDD2894 | [1] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DA-2 Probe Info |
![]() |
N.A. | LDD0070 | [2] |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Crizotinib | Small molecular drug | D03ZBT | |||
Entrectinib | Small molecular drug | D0O0LS | |||
Fostamatinib | Small molecular drug | DB12010 | |||
Lorlatinib | . | D0AF6O |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Ab-106 | Small molecular drug | D2KV8B | |||
Tpx-0005 | . | D05NFR |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Ds-6051 | . | D0N0DU |
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Pmid24432909c8e | Small molecular drug | D0K5UF |
Patented
References